CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).
Shi-Yi LiuFeiyan WangWei TanLi ZhangFangfang DaiYanqing WangYaqi FanMengqin YuanDongyong YangYajing ZhengZhimin DengYeqiang LiuYanxiang ChengPublished in: Cancer cell international (2020)
CTLA4 has a profound impact on the landscape of TILs and genetic mutation, and can be used as the biomarker with high prognosis value in ccRCC.